SUPPLEMENTARY FINANCIAL INFORMATION

(Unaudited) (thousands, except per share amounts and as noted)

The Company’s fiscal year is the 52-week or 53-week period ending on the Saturday closest to the last day in October. The Company's interim periods operates on a 4-4-5 fiscal calendar, where each fiscal quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. The Company's fiscal year quarterly financial information for fiscal 2016 and fiscal 2015:



	4Q16		3Q16		2Q16		1Q16		4Q15		3Q15		2Q15		1Q15
Revenue	1,003,623		869,591		778,766		769,429		978,722		863,365		821,019		771,986
Cost of sales	336,936		297,301		267,863		292,136		336,926		294,328		276,197		268,379
Gross margin	666,687		572,290		510,903		477,293		641,796		569,037		544,822		503,607
% of Revenue	66.4	%	65.8	%	65.6	%	62.0	%	65.6	%	65.9	%	66.4	%	65.2	%
Research and development	172,926		163,227		160,235		157,428		170,736		160,784		154,233		151,706
Selling, marketing, general and administrative	118,881		122,909		112,186		107,462		121,400		120,030		117,371		120,171
Special charges	—		—		13,684		—		—		—		—		—
Other operating expense (a)	—		—		—		—		223,672		—		—		—
Amortization of intangibles	17,899		17,447		17,419		17,358		17,358		22,954		24,210		23,796
Total operating expenses	309,706		303,583		303,524		282,248		533,166		303,768		295,814		295,673
Operating income	356,981		268,707		207,379		195,045		108,630		265,269		249,008		207,934
% of Revenue	36	%	31	%	27	%	25	%	11	%	31	%	30	%	27	%
Nonoperating (income) expenses:
Interest expense (b)	38,764		18,476		18,455		13,062		6,739		6,755		6,880		6,656
Interest income	(7,114	)	(5,665	)	(5,243	)	(3,199	)	(2,343	)	(2,229	)	(2,009	)	(2,044	)
Other, net	1,897		(504	)	(743	)	3,005		(443	)	1,265		(1,052	)	2,552
Total nonoperating (income) expense	33,547		12,307		12,469		12,868		3,953		5,791		3,819		7,164
Income before income taxes	323,434		256,400		194,910		182,177		104,677		259,478		245,189		200,770
% of Revenue	32	%	29	%	25	%	24	%	11	%	30	%	30	%	26	%
Provision for income taxes (c)	27,277		25,970		24,337		17,673		8,372		43,000		39,851		22,013
Net income	296,157		230,430		170,573		164,504		96,305		216,478		205,338		178,757
% of Revenue	30	%	26	%	22	%	21	%	10	%	25	%	25	%	23	%
Basic earnings per share	0.96		0.75		0.55		0.53		0.31		0.69		0.66		0.57
Diluted earnings per share	0.95		0.74		0.55		0.52		0.30		0.68		0.65		0.57
Shares used to compute earnings per share (in thousands):
Basic	307,854		307,135		308,790		311,166		312,829		313,877		312,660		311,274
Diluted	311,633		310,558		312,250		314,793		316,571		318,187		317,047		315,684
Dividends declared per share	0.42		0.42		0.42		0.40		0.40		0.40		0.40		0.37

a) The Company converted the benefits provided to participants in the Company’s Irish defined benefits pension plan to benefits provided under the Company’s Irish defined contribution plan. As a result, the Company recorded expenses of $223.7 million, including settlement charges, legal, accounting and other professional fees to settle the pension obligation.

b) Interest expense in the fourth quarter of fiscal 2016 includes $13.7 million related to accelerated amortization of fees associated with the bridge financing commitments related to the proposed Linear acquisition.

c) Provision for income taxes in the fourth quarter of fiscal 2015 includes a benefit of $13.0 million for the reversal of certain prior period tax liabilities and in the first quarter of fiscal 2015 includes a tax benefit of $7.0 million from the reinstatement of the U.S. federal research and development tax credit in December 2014 retroactive to January 1, 2014 and a tax benefit of $3.8 million as a result of an acquisition accounting adjustment.